首页 | 本学科首页   官方微博 | 高级检索  
     


Genomic characterization of response to chemoradiation in urothelial bladder cancer
Authors:Neil B. Desai MD  Sasinya N. Scott MPH  Emily C. Zabor MS  Eugene K. Cha MD  Joseph Hreiki MD  John P. Sfakianos MD  Ricardo Ramirez PhD  Aditya Bagrodia MD  Jonathan E. Rosenberg MD  Dean F. Bajorin MD  Michael F. Berger PhD  Bernard H. Bochner MD  Michael J. Zelefsky MD  Marisa A. Kollmeier MD  Irina Ostrovnaya PhD  Hikmat A. Al‐Ahmadie MD  David B. Solit MD  Gopa Iyer MD
Affiliation:1. Department of Radiation Oncology, University of Texas Southwestern, Dallas, Texas;2. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York;3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York;4. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York;5. Weill Cornell Medical College, Cornell University, New York, New York;6. Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York;7. Weill Cornell Graduate School of Medical Science, Cornell University, New York, New York;8. Marie‐Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York;9. Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;10. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York;11. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
Abstract:
Keywords:bladder chemoradiation  bladder preservation  excision repair cross‐complementation group 2 (ERCC2)  DNA damage response  radiation resistance
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号